Ambulatory IV infusion Pumps Market Report 2026

Ambulatory IV infusion Pumps Market Overview

• Ambulatory IV infusion Pumps market size has reached to $0.91 billion in 2025 • Expected to grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.8% • Growth Driver: Rising Surgical Procedures Are Fueling The Growth Of The Ambulatory IV Infusion Pump Market • Market Trend: Next-Generation Precision Pumps Redefine Accuracy And Data Reliability In Infusion Care • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Ambulatory IV infusion Pumps Market?

Ambulatory IV infusion pumps are portable medical devices used for controlled delivery of medication into the patient's body. The ambulatory IV infusion pumps market covered in this report is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. The disposable infusion pumps are single-use pumps used for the controlled delivery of medication into the patient's body. These are used for various applications such as chemotherapy or oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics or neonatology, hematology, and other applications that are used by various end-users such as hospitals, home healthcare, and others.

What Is The Ambulatory IV infusion Pumps Market Growth Forecast?

The ambulatory iv infusion pumps market size is expected to see steady growth in the next few years. It will grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing demand for remote therapy management, rising integration of connected healthcare devices, expansion of personalized drug delivery solutions, growing focus on reducing hospital stays, advancements in battery efficiency and pump miniaturization. Major trends in the forecast period include increasing adoption of portable and wearable infusion pumps, rising demand for home-based infusion therapies, growing integration of smart dose monitoring features, expansion of multi-therapy pump applications, enhanced focus on patient mobility and comfort.

Global Ambulatory IV infusion Pumps Market Segmentation

1) By Therapy: Chemotherapy Infusion Pumps, Anti-Infective Infusion Pumps, Other Therapies 2) By Application: Chemotherapy Or Oncology, Diabetes, Gastroenterology, Analgesia Or Pain Management, Pediatrics Or Neonatology, Hematology, Anti-Infective, Other Applications 3) By Patient Care Setting: Hospitals, Home Healthcare, Other End Users Subsegments: 1) By Chemotherapy Infusion Pumps: Continuous Chemotherapy Infusion Pumps, Cyclic Chemotherapy Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps for Chemotherapy 2) By Anti-Infective Infusion Pumps: Antibiotic Infusion Pumps, Antiviral Infusion Pumps, Antifungal Infusion Pumps 3) By Other Therapies: Pain Management Infusion Pumps, Nutritional Infusion Pumps (Total Parenteral Nutrition), Hormonal Therapy Infusion Pumps, Hydration Infusion Pumps

What Is The Driver Of The Ambulatory IV infusion Pumps Market?

The rising number of surgical procedures is expected to propel the growth of the ambulatory IV infusion pumps market going forward. Surgical procedures refer to medical interventions or treatments that involve making incisions or using invasive techniques to access and treat internal or external areas of the body. Ambulatory IV infusion pumps enable the controlled administration of fluids, medications, and anesthetics during surgical procedures, ensuring a precise and continuous flow, thereby enhancing patient safety and surgical efficiency. For instance, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, cosmetic procedure volumes have risen by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Therefore, the rising number of surgical procedures drives the growth of the ambulatory IV infusion pumps industry.

Key Players In The Global Ambulatory IV infusion Pumps Market

Major companies operating in the ambulatory iv infusion pumps market are Baxter International Inc, Becton Dickinson and Company, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc, Medtronic plc, Mindray Medical International Limited, Nipro Corporation, Moog Inc, Zyno Medical LLC, Micrel Medical Devices SA, JMS Co Ltd, Eitan Medical, SOOIL Development Co Ltd, Ypsomed Holding AG, Arcomed AG, Comen Medical, Flowonix Medical, Akas Infusion, CME Medical

Global Ambulatory IV infusion Pumps Market Trends and Insights

Major companies operating in the ambulatory IV infusion pumps market are focusing on developing innovative advancements such as precision infusion pumps to enhance the accuracy, consistency, and data reliability of infusion therapy. A precision infusion pump is an advanced infusion device designed to deliver medications and fluids with highly controlled accuracy while minimizing variability across diverse clinical conditions. For instance, in April 2025, ICU Medical, a US-based developer and manufacturer of medical infusion technologies, launched the Plum Solo and Plum Duo precision IV pumps. The devices introduce a high-accuracy delivery mechanism supported by integrated digital functions that improve infusion consistency regardless of environmental or setup factors. They also expand a unified infusion platform that strengthens medication management, supports full electronic health record interoperability, and provides clinicians with more reliable real-time infusion data.

What Are Latest Mergers And Acquisitions In The Ambulatory IV infusion Pumps Market?

In May 2025, ICU Medical Inc., a United States-based provider of infusion therapy systems, ambulatory IV infusion pumps, critical care medical devices, and related consumables, partnered with Otsuka Pharmaceutical Factory, Inc., to strengthen IV solutions manufacturing capacity and innovation in North America. With this partnership, the companies aim to enhance supply chain resiliency and introduce advanced PVC-free IV solution technologies to better support North American healthcare providers. Otsuka Pharmaceutical Factory, Inc. is a Japan-based provider of clinical nutrition products and IV solutions manufactured across its extensive global production network.

Regional Outlook

North America was the largest region in the ambulatory IV infusion pumps market in 2025. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ambulatory IV infusion Pumps Market?

The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.